A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

NCT05895136 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis
Decompensated Cirrhosis of Liver
Acute on Chronic Liver Failure (ACLF)

Interventions

DRUG: Human albumin
DRUG: Enoxaparin
DRUG: Standard medical treatment

Sponsor

European Foundation for Study of Chronic Liver Failure

Collaborators

[object Object]